Sarah Ford | April 18, 2014
Researcher Examines Impact of Extra Chromosome on Acute Myeloid Leukemia
David Gordon, MD, PhD at Dana Farber Cancer Institute is a CureSearch Young Investigator examining the impact of trisomy 8 on acute myeloid leukemia (AML). Of the 500 children diagnosed with AML each year, between 10-20% of an extra chromosome 8, called trisomy 8.
Dr. Gordon suspects that trisomy 8 contributes to the creation of cancerous cells because certain genes are expressed when an abnormal number of chromosomes are present. Using three cell lines he previously developed, Dr. Gordon spent the first year of his CureSearch grant screening the cell lines for new AML target genes and investigating the impact of trisomy 8 in blood cell development.
In the coming year, Dr. Gordon will explore how these genes, and their interaction with trisomy 8, lead to the development of AML.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Senior Accountant (Full-Time)
Position: Senior Accountant Department: Finance Reports to: Controller America’s Charities is a 501(c)(3) membership-based nonprofit organization. Since 1980, America’s Charities has been a pioneer in…
Read Article
Join Feeding America and Take Action During Hunger Action Month
No one should have to go hungry in the richest country in the world — yet millions of Americans don’t have enough to eat. Our…
Read Article
Childhood Cancer Awareness Month
Every September, childhood cancer organizations around the world come together in recognition of Childhood Cancer Awareness Month, with a goal to increase awareness and raise funds for…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
